The activated phenotype of CD103− CD39+ cells, and their relative scarceness when compared to CD103+ CD39+ cells, suggested CD103− CD39+ might rapidly differentiate towards tissue-resident CD103+ CD39+ cells when exposed to the tumor micro-environment. This evidence concerns the gene ENTPD1 and neoplasm.